The American College of Medical Genetics and Genomics has appointed David Flannery to medical director. Flannery is board-certified in both clinical genetics and pediatrics, and he joins ACMG from the Medical College of Georgia where he served in a variety of clinical, academic, and medical staff leadership positions since 1984, including professor of pediatrics and chief of the genetics division. He is a founding fellow of ACMG and he is currently the ACMG representative to the American Medical Association's CPT Advisory Committee.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.